Insider Trading Alert - OPK, HAR And WEX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 20, 2014, 164 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $87.78 to $643,360,199,551.68.

Highlighted Stocks Traded by Insiders:

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 27,600 shares at $8.53 on Feb. 20, 2014. Following this transaction, the CEO & Chairman owned 139.3 million shares meaning that the stake was reduced by 0.02% with the 27,600-share transaction.

The shares most recently traded at $9.00, up $0.47, or 5.19% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 20,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 4.1 million shares per day over the past 30 days. Opko Health has a market cap of $3.5 billion and is part of the health care sector and health services industry. Shares are up 0.47% year-to-date as of the close of trading on Thursday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Harman International Industries (HAR) - FREE Research Report

Stacey John who is EVP and Chief HR Officer at Harman International Industries sold 11,042 shares at $102.95 on Feb. 20, 2014. Following this transaction, the EVP and Chief HR Officer owned 0 shares meaning that the stake was reduced by 100% with the 11,042-share transaction.

The shares most recently traded at $105.19, up $2.24, or 2.13% since the insider transaction. Historical insider transactions for Harman International Industries go as follows:

  • 4-Week # shares sold: 2,143
  • 12-Week # shares sold: 2,143
  • 24-Week # shares sold: 99,416

The average volume for Harman International Industries has been 814,200 shares per day over the past 30 days. Harman International Industries has a market cap of $6.9 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 26.81% year-to-date as of the close of trading on Thursday.

Majority of revenue growth to come from MOST systems in high-end luxury cars. The stock currently has a dividend yield of 1.17%. The company has a P/E ratio of 45.3. Currently there are 4 analysts that rate Harman International Industries a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAR - FREE

TheStreet Quant Ratings rates Harman International Industries as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Harman International Industries Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WEX (WEX) - FREE Research Report

Smith Melissa D who is CEO and President, WEX Inc. at WEX sold 1,850 shares at $92.95 on Feb. 20, 2014. Following this transaction, the CEO and President, WEX Inc. owned 31,798 shares meaning that the stake was reduced by 5.5% with the 1,850-share transaction.

The shares most recently traded at $93.44, up $0.49, or 0.52% since the insider transaction. Historical insider transactions for WEX go as follows:

  • 4-Week # shares sold: 1,835
  • 12-Week # shares sold: 5,035
  • 24-Week # shares sold: 41,264

The average volume for WEX has been 215,200 shares per day over the past 30 days. WEX has a market cap of $3.6 billion and is part of the services sector and diversified services industry. Shares are down 7.6% year-to-date as of the close of trading on Thursday.

WEX Inc. provides corporate card payment solutions in North and South America, the Asia Pacific, and Europe. It operates in two segments, Fleet Payment Solutions and Other Payment Solutions. The company has a P/E ratio of 23.9. Currently there are 4 analysts that rate WEX a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WEX - FREE

TheStreet Quant Ratings rates WEX as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full WEX Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs